HUGE

FSD Pharma Inc.

0.18 USD
+0.01 (+5.56%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

FSD Pharma Inc. stock is down -48.43% since 30 days ago. The next earnings date is Jul 5, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 33.33% of the previous 6 June’s closed higher than May.

About FSD Pharma Inc.

FSD Pharma Inc. operates as a pharmaceutical research and development company. Its lead candidate includes FSD-201 that is in the Phase II clinical trial to treat COVID-19 disease. The company also focuses on Lucid-PSYCH, a psychoactive molecule identified for the potential treatment of neuropsychiatric disorders.